David R. Williams

7.4k citations

59 papers · 4.0k indexed · 1 hit paper · h-index 30

Neurology top 0.2%
Physiology top 2%
Cellular and Molecular Neuroscience top 2%
Neurology top 1%
Molecular Biology

Co-authors: Andrew J. Lees Janice L. Holton Tamás Révész Alan Pittman Rohan de Silva Luke A. Massey Laura Silveira‐Moriyama Sean S. O’Sullivan
Topics: Parkinson's Disease Mechanisms and Treatments (35 papers)Neurological disorders and treatments (25 papers)Botulinum Toxin and Related Neurological Disorders (12 papers)
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Brain Neurology The Lancet Neurology
Partner nations: Australia United Kingdom United States

In The Last Decade

David R. Williams

58 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

2005 517 citations David R. Williams, Rohan de Silva et al. Brain profile →

Peers

Countries citing papers authored by David R. Williams

Since Specialization

Citations

This map shows the geographic impact of David R. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Williams more than expected).

Fields of papers citing papers by David R. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Williams. The network helps show where David R. Williams may publish in the future.

Co-authorship network of co-authors of David R. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Williams. A scholar is included among the top collaborators of David R. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Williams. David R. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Measuring disease progression and disability in orthostatic tremor 2018 ·Parkinsonism & Related Disorders ·Nirosen Vijiaratnam,(unknown),Eldho Paul,Kelly Bertram,David R. Williams	6
2	Prospective Characterization of Cognitive Function in Typical and ‘Brainstem Predominant’Progressive Supranuclear Palsy Phenotypes 2018 ·Journal of Movement Disorders ·Claire Lee,David R. Williams,Jacqueline F. I. Anderson	9
3	Reversal of long term potentiation-like plasticity in primary motor cortex in patients with progressive supranuclear palsy 2017 ·Clinical Neurophysiology ·Matteo Bologna,Kelly Bertram,Giulia Paparella,(unknown),Daniele Belvisi,Antonella Conte,Antonio Suppa,David R. Williams,Alfredo Berardelli	11
4	Cardio-protective effects of combined l-arginine and insulin: Mechanism and therapeutic actions in myocardial ischemia-reperfusion injury 2015 ·European Journal of Pharmacology ·Kylie Venardos,Niwanthi W. Rajapakse,David R. Williams,Louise E. See Hoe,Jason N. Peart,David M. Kaye	11
5	Delays to the diagnosis of cervical dystonia 2015 ·Journal of Clinical Neuroscience ·Kelly Bertram,David R. Williams	21
6	The midbrain to pons ratio 2013 ·Neurology ·Luke A. Massey,Hans Rolf Jäger,Dominic Paviour,Sean S. O’Sullivan,Helen Ling,David R. Williams,Constantinos Kallis,Janice L. Holton,Tamás Révész,David J. Burn,Tarek Yousry,Andrew J. Lees,Nick C. Fox,Caroline Micallef	120
7	MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy 2012 ·Journal of Neurology ·Igor Petrović,Antonio Martín‐Bastida,Luke A. Massey,Helen Ling,Sean S. O’Sullivan,David R. Williams,Janice L. Holton,Tamás Révész,James W. Ironside,Andrew J. Lees,Laura Silveira‐Moriyama	16
8	Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy 2012 ·Movement Disorders ·Luke A. Massey,Caroline Micallef,Dominic Paviour,Sean S. O’Sullivan,Helen Ling,David R. Williams,Constantinos Kallis,Janice L. Holton,Tamás Révész,David J. Burn,Tarek Yousry,Andrew J. Lees,Nick C. Fox,Hans Rolf Jäger	149
9	Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease 2011 ·Movement Disorders ·(unknown),Nellie Georgiou‐Karistianis,Owen White,Lynette Millist,David R. Williams,Andrew Churchyard,Joanne Fielding	24
10	Postural instability, frontotemporal dementia, and ophthalmoplegia: Clinicopathological case 2011 ·Movement Disorders ·Francisco Cardoso,John R. Hodges,Andrew Evans,Tamás Révész,David R. Williams	1
11	What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)? 2010 ·Movement Disorders ·David R. Williams,Andrew J. Lees	85
12	Hyposmia in progressive supranuclear palsy 2010 ·Movement Disorders ·Laura Silveira‐Moriyama,Graham R.V. Hughes,Alistair Church,Hilary Ayling,David R. Williams,Aviva Petrie,Janice L. Holton,Tamás Révész,Ann E. Kingsbury,Huw R. Morris,David J. Burn,Andrew J. Lees	42
13	Concomitant progressive supranuclear palsy and multiple system atrophy: More than a simple twist of fate? 2009 ·Neuroscience Letters ·Laura Silveira‐Moriyama,Ana Marcos González,Sean S. O’Sullivan,David R. Williams,Luke A. Massey,Laura Parkkinen,Zeshan Ahmed,Rohan de Silva,(unknown),Tamás Révész,Andrew J. Lees,Janice L. Holton	15
14	Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome 2007 ·Brain ·David R. Williams,Janice L. Holton,Catherine Strand,Alan Pittman,Rohan de Silva,Andrew J. Lees,Tamás Révész	303
15	Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy 2007 ·Movement Disorders ·David R. Williams,Alan Pittman,Tamás Révész,Andrew J. Lees,Rohan de Silva	19
16	Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy 2007 ·Movement Disorders ·David R. Williams,Janice L. Holton,Kate Strand,Tamás Révész,Andrew J. Lees	156
17	Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonismbreakdown → 2005 ·Brain ·David R. Williams,Rohan de Silva,Dominic Paviour,Alan Pittman,Hilary Watt,Linda Kilford,Janice L. Holton,Tamás Révész,Andrew J. Lees	517
18	Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration 2005 ·Journal of Medical Genetics ·Alan Pittman,A. J. W. Myers,Patrick M. Abou‐Sleiman,Hon‐Chung Fung,M. Kaleem,Lauren Marlowe,Jaime Duckworth,Doris G. Leung,David R. Williams,Linda Kilford,Natalie Thomas,Christopher M. Morris,Dennis W. Dickson,Nicholas Wood,John Hardy,Andrew Lees,(unknown)	187
19	EMU Shoulder Injury Tiger Team Report 2003 ·NASA Technical Reports Server (NASA) ·David R. Williams,Brian J. Johnson	32
20	Hypoglycaemia induced by exogenous insulin –‘human’ and animal insulin compared 2000 ·Diabetic Medicine ·(unknown),David R. Williams,(unknown),Cathy Bennett,Pat Spoor	11

About David R. Williams

David R. Williams is a scholar working on Neurology, Neurology and Sensory Systems, having authored 59 papers that have together received 4.0k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (25 papers) and Botulinum Toxin and Related Neurological Disorders (12 papers). The work is most often cited by research in Neurology (3.0k citations), Neurology (855 citations) and Cellular and Molecular Neuroscience (1.0k citations). David R. Williams has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Andrew J. Lees, Janice L. Holton, Tamás Révész, Alan Pittman, Rohan de Silva, Luke A. Massey, Laura Silveira‐Moriyama, Sean S. O’Sullivan, Dominic Paviour and Linda Kilford. Their work appears in journals such as Brain, Neurology and The Lancet Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact